Your account is not claimed yet. You can sign up with ORCID to claim your account.

Thomas P Loughran (David J Feith, David Feith)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 14

Top Venues

Blood

Cancers

British journal of haematology

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan E Brammer, Karen Ballen, Lubomir Sokol, Christiane Querfeld, Ryotaro Nakamura, Anjali Mishra, Eric M Mclaughlin, Thomas P Loughran, Nazli Azimi, Thomas Waldmann, Yutaka Tagaya, Thomas Loughran
Effective Treatment with the Selective Cytokine Inhibitor BNZ-1 Reveals the Cytokine Dependency of T-LGL Leukemia. Blood (2023)
Kelsey H Fisher-Wellman, Miki Kassai, James T Hagen, P Darrell Neufer, Mark Kester, Thomas P Loughran, Charles E Chalfant, Thomas P Loughran, Su-Fern Tan, Todd E Fox, Johnson Ung, Gemma Fabriàs, Jose' Luis Abad, Arati Sharma, Upendarrao Golla, David F Claxton, Jeremy J P Shaw, Debajit Bhowmick, Myles C Cabot
Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia. Cancers 15 (6) (2023)
Kelsey H Fisher-Wellman, Miki Kassai, James T Hagen, P Darrell Neufer, Mark Kester, Thomas P Loughran, Charles E Chalfant, Thomas P Loughran, Su-Fern Tan, Todd E Fox, Johnson Ung, Gemma Fabriàs, Jose' Luis Abad, Arati Sharma, Upendarrao Golla, David F Claxton, Jeremy J P Shaw, Debajit Bhowmick, Myles C Cabot
Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute Myeloid Leukemia. Cancers 15 (6) (2023)
Constance Baer, Shunsuke Kimura, Mitra Shumsher Rana, Andrew B Kleist, Tim Flerlage, Thomas P Loughran, Peter J Chockley, Wencke Walter, Manja Meggendorfer, Thomas L Olson, HeeJin Cheon, Kristine C Olson, Aakrosh Ratan, Martha-Lena Mueller, James M Foran, Laura J Janke, Chunxu Qu, Shaina N Porter, Shondra M Pruett-Miller, Ravi C Kalathur, Claudia Haferlach, Wolfgang Kern, Elisabeth Paietta, Paul Glyndwr Thomas, M Madan Babu, Thomas P Loughran, Ilaria Iacobucci, Torsten Haferlach, Charles G Mullighan
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk. Nature genetics 54 (5) (2022)
HeeJin Cheon, Jeffrey C Xing, Katharine B Moosic, Johnson Ung, Vivian W Chan, David S Chung, Mariella F Toro, Omar Elghawy, John S Wang, Cait E Hamele, Ross Cameron Hardison, Thomas L Olson, Su-Fern Tan, Thomas P Loughran, Aakrosh Ratan, Thomas P Loughran
Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia. Blood 139 (20) (2022)
Jorn L J C Assmann, Leticia G Leon, Christiaan J Stavast, Sanne E van den Bogaerdt, Joyce Schilperoord-Vermeulen, Yorick Sandberg, Mar Bellido, Stefan J Erkeland, Thomas P Loughran, Thomas P Loughran, Anton W Langerak
miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia. Leukemia (2021)
Thomas L Olson, HeeJin Cheon, Jeffrey C Xing, Kristine C Olson, Umadevi Paila, Cait E Hamele, Yaseswini Neelamraju, Bryna C Shemo, Matt Schmachtenberg, Shriram K Sundararaman, Mariella F Toro, Cheryl A Keller, Emily A Farber, Suna Onengut-Gumuscu, Francine E Garrett-Bakelman, Ross Cameron Hardison, Thomas P Loughran, Aakrosh Ratan, Thomas P Loughran
Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias. Blood 138 (8) (2021)
Francis R LeBlanc, Jennifer M Pearson, Su-Fern Tan, HeeJin Cheon, Jeffrey C Xing, Wendy Dunton, Thomas P Loughran, Thomas P Loughran
Sphingosine kinase-2 is overexpressed in large granular lymphocyte leukaemia and promotes survival through Mcl-1. British journal of haematology 190 (3) (2020)
T Tiffany Wang, Jun Yang, Shubha Dighe, Matthew W Schmachtenberg, Nathan T Leigh, Emily Farber, Suna Onengut-Gumuscu, Thomas P Loughran, Aakrosh Ratan, Thomas P Loughran, Thomas L Olson
Whole Genome Sequencing of Spontaneously Occurring Rat Natural Killer Large Granular Lymphocyte Leukemia Identifies JAK1 Somatic Activating Mutation. Cancers 12 (1) (2020)
Kristine C Olson, Katharine B Moosic, Marieke K Jones, Paige M K Larkin, Thomas L Olson, Mariella F Toro, Todd E Fox, Thomas P Loughran, Thomas P Loughran
Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations. Cancer medicine 9 (18) (2020)
Jennifer M Pearson, Su-Fern Tan, Arati Sharma, Charyguly Annageldiyev, Todd E Fox, Jose Luis Abad, Gemma Fabrias, Dhimant Desai, Shantu Amin, Hong-Gang Wang, Myles C Cabot, David F Claxton, Mark Kester, Thomas P Loughran, Thomas P Loughran
Ceramide Analogue SACLAC Modulates Sphingolipid Levels and MCL-1 Splicing to Induce Apoptosis in Acute Myeloid Leukemia. Molecular cancer research : MCR 18 (3) (2019)
Susan B Nyland, Thomas P Loughran, Mary Poss, Thomas L Olson, Daniel J Krissinger, Bernard J Poiesz, Francis W Ruscetti, Thomas P Loughran
Retroviral sero-reactivity in LGL leukaemia patients and family members. British journal of haematology 188 (4) (2019)
Jun Yang, Francis R LeBlanc, Shubha A Dighe, Cait E Hamele, Thomas L Olson, Thomas P Loughran, Thomas P Loughran
TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia. Blood 131 (25) (2018)
Paige M Kulling, Kristine C Olson, Thomas L Olson, Thomas P Loughran, Thomas P Loughran
Vitamin D in hematological disorders and malignancies. European journal of haematology 98 (3) (2016)

Thomas P Loughran.css-eqlu8i{font-size:small;padding-left:4px;} (David J Feith, David Feith)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas P Loughran (David J Feith, David Feith)